ReproNovo

ReproNovo, established in 2021, is a company with a focus on reproductive medicine and women`s health. The team, composed of experts with years of experience, is dedicated to developing innovative therapeutic solutions targeting male and female infertility, as well as conditions like adenomyosis. The team has a proven track record of designing and executing clinical programs and bringing therapies to market. Headquartered in Lausanne, Switzerland, with development teams in Copenhagen, Denmark, and Barcelona, Spain, ReproNovo aims to address critical gaps in reproductive medicine worldwide. Their focus on research and commercialization of novel treatments is backed by international investors who share a commitment to advancing this field. ReproNovo`s approach to developing new treatments for infertility is poised to benefit a significant portion of the global population, as they strive to redefine fertility treatment and improve outcomes for their patients.